Efficacy and Effectiveness of Antidepressants: Current Status of Research
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Background: This paper examines the current status of research on the efficacy and effectiveness of antidepressants. Methods: This paper reviews four meta-analyses of efficacy trials submitted to America’s Food and Drug Administration (FDA) and analyzes STAR*D (Sequenced Treatment Alternatives to Relieve Depression), the largest antidepressant effectiveness trial ever conducted. Results: Meta-analyses of FDA trials suggest that antidepressants are only marginally efficacious compared to placebos and document profound publication bias that inflates their apparent efficacy. These meta-analyses also document a second form of bias in which researchers fail to report the negative results for the pre-specified primary outcome measure submitted to the FDA, while highlighting in published studies positive results from a secondary or even a new measure as though it was their primary measure of interest. The STAR*D analysis found that the effectiveness of antidepressant therapies was probably even lower than the modest one reported by the study authors with an apparent progressively increasing dropout rate across each study phase. Conclusions: The reviewed findings argue for a reappraisal of the current recommended standard of care of depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the STAR-D trial, the largest naturalistic study of antidepressants so far conducted, the remission rate at one year for all participants taking antidepressants was 2.7% (108/4000), and 92.9% relapsed or dropped out (Pigott 2010).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Pigott 2010
In the citing paper
“Currently available antidepressant medications largely target monoamine pathways, but treatment of depression is only effective in about a third to a half of patients.1, 2”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [1]
In the citing paper
“current treatment of depression is only effective in about a third to a half of patients,1, 2”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [1]
In the citing paper
“In this study, 84 % of participants in this study answered in the affirmative to a question about whether they felt antidepressants had reduced their depression, a number well above that suggested by efficacy studies”
From ‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants (2016) · cites this paper as [26]
In the citing paper
“An understanding of users’ own experiences of antidepressant use is increasingly important in the context of growing doubts about the effectiveness of antidepressant treatment [5, 26], concerns about side effects [27] and withdrawal effects [28].”
From ‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants (2016) · cites this paper as [26]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“recommendations for distinguishing between specific and nonspecific treatment effects, the first one being having an active placebo arm to reduce the likelihood of unblinding and thereby control the potential role of side effects in enhancing patients’ expectation of improvement. Real-World Effectiveness of Antidepres…”
BackgroundRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 1×
“p. 129] (table 2 ). 2 Table 2. Survival analysis by treatment step of patients who entered continuing care in remission T02 As mentioned earlier, STAR*D was designed to identify the best next-step treatment for the many patients who fail to get adequate relief from their initial SSRI trial. Due to the high study dropo…”
MethodKirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
HARKing: Hypothesizing after the results are known
Kerr, N. L. (1998) · Personality and Social Psychology Review · doi:10.1207/s15327957pspr0203_4 · Cited by 1,989
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
The Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · cited 1×
“observed that early RCTs often enrolled hospitalized patients who were less responsive to placebo, whereas more recent trials typically enroll highly selected outpatients, contacted through mass media advertisements, who may be less severely depressed. In a meta-analysis of 75 RCTs published between 1981 and 2000, Wal…”
BackgroundSequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 1×
“p. 739].The conclusion section of the research design article of STAR*D states: ‘STAR * D uses a randomized, controlled design to evaluate both the theoretical principles and clinical beliefs that currently guide the management of treatment-resistant depression in terms of symptoms, function, satisfaction, side-effect…”
Background
Research works printed but not linked: 9
- 10.1001%2Fjama.263.10.1385 · DOI
- 10.1176%2Fappi.ajp.163.7.1161 · doi:10.1176/appi.ajp.163.7.1161 · Paper page
- 10.1176%2Fappi.ajp.163.9.1519 · DOI · Paper page
- 10.1176%2Fappi.ajp.163.9.1531 · DOI
- 10.1176%2Fappi.ajp.163.11.1905 · doi:10.1176/appi.ajp.163.11.1905 · Paper page
- 10.1176%2Fappi.ajp.164.5.739 · DOI · Paper page
- 10.1001%2Fjama.287.13.1646 · DOI
- 10.1159%2F000235736 · DOI · Paper page
- 10.1016%2FS0895-4356%2899%2900161-4 · DOI · Paper page
Cited by
Items 201–300 of 345
D’Elia, A., Bawor, M., Dennis, B. B., Bhatt, M., Litke, K., McCabe, K., Whattam, J., Garrick, L., O’Neill, L., Simons, S., et al. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00596-z · Cited by 11
Amen, D., Jourdain, M., Taylor, D. V., Pigott, H. E., & Willeumier, K. (2013) · PubMed · Cited by 9
Self-citationOhaeri, J. U., & Awadalla, A. W. (2012) · Medical Science Monitor · doi:10.12659/msm.882521 · Cited by 9
“Furthermore, the demonstrated high prevalence of comorbidity calls for specific treatment trials on comorbid GAD/MDD, because there are no adequate treatments for this condition [26], and there are doubts about the effectiveness of SSRIs/SNRIs [96].”
BackgroundStreiner, D. L. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000901 · Cited by 10
“Among the many criticisms leveled at it, one of the most telling is the fact that in the protocol submitted to the Food and Drug Administration (FDA), the outcome measure was the Hamilton Rating Scale for Depression.14 However, the papers coming from the trial reported the results for the Self-Reported Quick Inventory…”
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Basso, V., Döbrössy, M. D., Thompson, L. H., Kirik, D., Fuller, H. R., & Gates, M. A. (2024) · Biology · doi:10.3390/biology13090690 · Cited by 12
Vijapura, S., Laferton, J. A. C., Mintz, D. L., Kaptchuk, T. J., & Wolfe, D. J. (2015) · Academic Psychiatry · doi:10.1007/s40596-015-0470-2 · Cited by 9
Exercise for Mood and Anxiety Disorders: A Review of Efficacy, Mechanisms, and Barriers
Szuhany, K. L., Smits, J. A. J., Asmundson, G. J. G., & Otto, M. W. (2014) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199935291.013.20 · Cited by 9
Alternating current cranial electrotherapy stimulation (CES) for depression
Kavirajan, H., Lueck, K., & Chuang, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010521 · Cited by 9
Do GPs and psychiatrists recommend alternatives when prescribing anti-depressants?
Read, J., Gibson, K., & Cartwright, C. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.069 · Cited by 7
“These increases occur despite evidence that their efficacy has been overestimated (Kirsch et al., 2008; Pigott et al., 2010), and their adverse effects minimized.”
Dual-Brain Psychology: A novel theory and treatment based on cerebral laterality and psychopathology
Schiffer, F. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.986374 · Cited by 7
“DBP uses unilateral brain stimulation or inhibition as well as medications such as buprenorphine, which unlike the antidepressants (Pigott et al., 2010), have a large effect size.”
BackgroundConstantino, J. L., van Dalfsen, J. H., Massetti, S., Kamphuis, J., & Schoevers, R. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111251 · Cited by 10
Miedlich, S. U., & Lamberti, J. S. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15301 · Cited by 13
“Publishedin2006,theSTAR*Dinvestigatorsreportedanoverallremis-sion rate of 67% based on patient self-report rather than the HRSD. 96 Study findings were later criticized due to flaws in study methods, including not using the HRSD to report remission and response rates andexcludingfromanalysispatientswhostartedcitalopra…”
InfluentialWorking with Complexity in Integrated Behavioral Health Settings
Baird, M. A., Peek, C. J., Gunn, W. B., & Valeras, A. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6889-9_14 · Cited by 9
Two-mode K-spectral centroid analysis for studying multivariate longitudinal profiles
Heylen, J., Mechelen, I. V., Fried, E. I., & Ceulemans, E. (2016) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2016.03.009 · Cited by 6
“large meta-analyses have shown that antidepressants only slightly outperform placebos [38,39,40,41].”
BackgroundDiffering antidepressant maintenance methodologies
Safer, D. J. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.021 · Cited by 9
A Network Approach to Depressive Disorders
Quinton, T. S., & Stain, H. J. (2019) · Journal of Rational-Emotive & Cognitive-Behavior Therapy · doi:10.1007/s10942-019-00320-8 · Cited by 7
Liberman, J. N., Pesa, J. A., Rui, P., Joshi, K., & Harding, L. (2023) · Medicine · doi:10.1097/md.0000000000032895 · Cited by 8
Modeling the Risks and Benefits of Depression Treatment for Children and Young Adults
Soeteman, D. I., Miller, M., & Kim, J. J. (2012) · Value in Health · doi:10.1016/j.jval.2012.03.1390 · Cited by 12
Brupbacher, G., Zander-Schellenberg, T., Straus, D., Porschke, H., Infanger, D., Gerber, M., von Känel, R., & Schmidt‐Trucksäss, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10174028 · Cited by 8
van Dalfsen, J. H., Kamphuis, J., Türkmen, C., Peen, J., Booij, S. H., van Oosterzee, K. P., Riese, H., Dekker, J., & Schoevers, R. A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119544 · Cited by 6
Wagner, J., Gambell, E., Gibbons, T., Martin, T. J., & Kaplan, J. S. (2024) · NeuroSci · doi:10.3390/neurosci5040045 · Cited by 10
“Self-medication for anxiety disorders with Cannabis sativa L. [3–7] is increasingly common due to incomplete efficacy and moderate side effect profiles with current prescription medications [8,9].”
Singh, K. P., Singh, P., Agrawal, P., & Agarwal, B. (2023) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2023.11502 · Cited by 6
“Globally, the numbers of clinical depressive cases are escalating rapidly in the general population, including pregnant women, despite the availability of various typical and atypical ADs, thus causing a treatment gap for effective control of the depressed population [8].”
BackgroundZhang, L.-W., Cui, C., Liu, C., Sun, L.-P., Ouyang, Y.-N., Li, L., Zhang, D.-L., & Yu, H.-L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112330 · Cited by 8
Exercise for the Prevention and Treatment of Depression
Alderman, B. L., Perdue, H. M., & Sarwani, A. H. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_496 · Cited by 8
de Jong, V., & Raz, A. (2011) · Cited by 9
Wong, J., Kurteva, S., Motulsky, A., & Tamblyn, R. (2021) · Medical Care · doi:10.1097/mlr.0000000000001658 · Cited by 8
The JNK signaling pathway as a potential new target for depression
Zhang, J., & Lin, W. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00157 · Cited by 6
Depression and Anxiety Disorders
Karamustafalıoğlu, O., & Yumrukçal, H. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg003.pub2 · Cited by 8
Гафаров, В. В., Громова, Е. А., Panov, D., Maksimov, V. N., Gagulin, I. V., & Гафарова, А. В. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-5-22-27 · Cited by 5
Zhu, W., Zhang, W., Yang, F., Cai, M., Li, X., Xiang, Y., Xiang, J. Y., Yang, Y., & Cai, D.-F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1108494 · Cited by 5
Mo, Y., Lei, Z., Chen, M., Deng, H., Liang, R., Yu, M., & Huang, H. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1287891 · Cited by 5
“However, even with a variety of treatments, some patients have persistent symptoms and do not fully recover (Pigott et al., 2010).”
BackgroundGeestelijke gezondheidszorg in de huisartspraktijk: psychiatriseren of normaliseren?
Verhaak, P. F. M. (2011) · Psychologie & gezondheid · doi:10.1007/s12483-011-0020-x · Cited by 5
Sundberg, T., Hussain‐Alkhateeb, L., & Falkenberg, T. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0865-3 · Cited by 6
“However, if they are not rationally used, and for too long periods, and especially if there is inadequate scientific evidence to inform appropriate clinical integration of pharmacological care [44–46], the prospect of”
BackgroundFunctions and Circuits of REM Sleep
Gazea, M., Rio‐Bermudez, C. D., Nissen, C., & Adamantidis, A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-813743-7.00017-7 · Cited by 9
Establishment of an Animal Model of Depression: The Serotonin Transporter Knockout Rat
Kidwell, M. (2019) · doi:10.26686/wgtn.17135999.v1 · Cited by 5
Pessoni, A. M., Arabe, L. B., Pancotti, L., Mansouri, S., D’Angelo, M., Huot, K., Marroquín-Rivera, A., Peralta, M. R., Zhao, C., Leboulleux, Q., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.001 · Cited by 6
Zhang, T., Wang, L., Bai, Y., Zhao, W., Wu, Y., Jiang, W., Fan, Q., & Qiu, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.499633 · Cited by 6
“However, even after having received multiple treatments, such as medications and/or psychotherapy, the majority of patients with MDD fail to recover completely from it and still present with depressive symptoms (5).”
BackgroundStassen, H. H., Bachmann, S., Bridler, R., Cattapan, K., & Seifritz, E. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01767-2 · Cited by 5
“And worst of all, there is no long-term cure for a substantial proportion of patients, for example, for 50–60% of patients with schizophrenic disorders [10], and for 35–50% of patients with major depression [11, 12].”
Primary care in the age of reform-not a time for complacency.
Baird, M. A. (2014) · PubMed · Cited by 4
Truzoli, R., Rovetta, C., Nola, E., Matteucci, L., & Viganò, C. A. (2019) · The Open Psychology Journal · doi:10.2174/1874350101912010012 · Cited by 4
Altman, B. R., Earleywine, M., & Leo, J. A. D. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.2020382 · Cited by 4
Excesos y alternativas de la salud mental en atención primaria
Lobo, A. O., & Bernstein, J. (2015) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc10(35)1055 · Cited by 9
The Need for Quality Improvement in Behavioral Health
Gaudiano, B. A., Dalrymple, K. L., D’Avanzato, C., & Bunaciu, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-26209-3_3 · Cited by 5
Widespread Methodological Problems Limit Validity of Meta-Analytic Results
Huf, W., Kalcher, K., & Kasper, S. F. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000322788 · Cited by 4
Do Pharmacotherapy and/or Psychotherapy Work in Depression? It Depends!
Hoyer, J., & Höfler, M. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000322634 · Cited by 4
Yao, L., Yan, R., & Sun, C. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1819436 · Cited by 5
Jain, R. K., Laliberté, F., Germain, G., Mahendran, M., Higa, S., Harrington, A., & Parikh, M. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.8.896 · Cited by 4
Problems in determining efficacy and effectiveness of antidepressants.
Möller, H. ‐., & Fountoulakis, K. Ν. (2011) · PubMed · Cited by 3
Gagulin, I. V., Громова, Е. А., Гафарова, А. В., & Гафаров, В. В. (2018) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2018-1-43-46 · Cited by 4
Liu, B., Yuan, M., Hu, Y. H., Ge, F., Wang, J., & Zhang, W. (2021) · PubMed Central · doi:10.12182/20210160101 · Cited by 6
Reynolds, G., Piers, R. J., & Cronin‐Golomb, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197564295.003.0010 · Cited by 3
Acupuncture for Depression: The Mechanism Underlying Its Therapeutic Effect
Muthmainah, M., & Nurwati, I. (2016) · Medical Acupuncture · doi:10.1089/acu.2016.1180 · Cited by 4
Pigott, H., & Alter, G. S. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000323614 · Cited by 3
Self-citationCosgrove, L., & Vaswani, A. (2018) · Springer eBooks · doi:10.1007/978-3-030-02732-2_3 · Cited by 7
An Editor’s Journey Ends, but the Journal’s Mission Continues
Fava, G. A. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524654 · Cited by 5
Upton, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85542-6.00003-2 · Cited by 4
Corruption impairs discussion on long term use of psychiatric drugs
Whitaker, R. B., & Cosgrove, L. (2015) · BMJ · doi:10.1136/bmj.h2953 · Cited by 3
On the conditions for objectivity : how to avoid bias in socially relevant research
Jukola, S. (2015) · Jyväskylä University Digital Archive (University of Jyväskylä) · Cited by 8
Efficacy of Music Therapy on Adolescents with Depressive Symptoms
Bellapu, A. S., Chemmanoor, S., Hu, M., Kim, N., & Clark, C. (2021) · Journal of Student Research · doi:10.47611/jsrhs.v10i4.2385 · Cited by 6
“Archer et al. (2012), Leichsenring et al. (2006), Moncrieff & Kirsch (2005), and Pigott et al. (2010) conducted metaanalyses and/or reviews.”
BackgroundDepression symptoms and core affect: Results from network and regression analyses
Vanags, E., & Raščevska, M. (2023) · Mental Health Science · doi:10.1002/mhs2.13 · Cited by 3
Dang, J., Bashmi, L., Meeneghan, S., White, J., Hedrick, R., Djurovic, J., Vanle, B., Nguyen, D., Almendarez, J., Ravets, P., et al. (2018) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.1802011 · Cited by 6
Patient and economic benefits of psychological support for noncompliant patients
Reed, P., Osborne, L. A., Whittall, C. M., Emery, S. J., & Truzoli, R. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.829880 · Cited by 6
“Providing remediation for depression and anxiety is not necessarily straightforward, and these conditions are, themselves, subject to noncompliance and treatment resistance (Gibson et al., 2010; Pigott et al., 2010; Bennabi et al., 2015).”
BackgroundMisiak, B., Rejek, M., Bielawski, T., Błoch, M., Samochowiec, J., Bąba-Kubiś, A., Gawęda, Ł., & Maciaszek, J. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.09.002 · Cited by 2
Muñoz‐Navarro, R., Pérez‐Jover, V., Esteller-Collado, G., Román, C. J. V.-D. H., Salgueiro, M., Llorca, A., Malonda-Vidal, E., Canet-Cortell, V., Moraga-García, M. J., Coloma‐Carmona, A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320857 · Cited by 2
“Although some studies have evaluated the effects of standard psychopharmacological treatments on neuropsychological processes, the results are still heterogeneous [61,77].”
Effects of Escitalopram on C reactive protein in patients of depression
Chittora, G., Rastogi, P., Razdan, R., & Songara, P. (2017) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2017.i02.11 · Cited by 1
A Patient Bill of Rights for Psychotropic Prescription: A Call for a Higher Standard of Care
Duncan, B. L., & Antonuccio, D. O. (2011) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2011.24061 · Cited by 2
“On the other hand, if one looks at the remission across all levels, which at each level was quite meager and less than typical placebo response, combined with a 51% adverse reaction profile after augmentation/switch, and a 58% relapse rate, a different conclusion would likely result [10, 56].”
Towards a Compendium of the Psychopathologies of Love
Levine, S. B. (2013) · Archives of Sexual Behavior · doi:10.1007/s10508-013-0242-6 · Cited by 3
Pigott, E. (2017) · NeuroRegulation · doi:10.15540/nr.4.1.28 · Cited by 3
“As Pigott et al. (2010) document, however, the researchers’ assumptions in calculating their theoretical remission rate are simply not true in the real world—and was certainly not true in STAR*D, since more patients dropped out in each step than remitted.”
BackgroundДмитриевна, Т. О., Агибалова, Т. В., Shustov, D. I., Shustova, S. A., Buzik, O. Z., & Petrosyan, Y. E. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0576-6 · Cited by 3
“Some of these [22, 23] showed relatively limited (statistically signifi cantly but clinically unimportant) advantages of antidepressants over placebo therapy.”
BackgroundWang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., Fang, J., & Li, Z. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13041 · Cited by 5
Pharmacometrics in Psychiatric Diseases
de Lange, E. C. M. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4939-1304-6_14 · Cited by 3
Cognitive-reminiscence therapy for the treatment of depression in young adults
Hallford, D. J. (2013) · Cited by 3
Psychosomatic Approach to Clinical Practice
Tossani, E., & Fava, G. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7119-6_7 · Cited by 2
Psychotherapy and psychiatric drugs in psychiatry: what relationship,and what hierarchy?
Carcione, A. (2011) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 3
Mindfulness-based Yoga intervention for women with elevated levels of depressive symptoms
Schuver, K. J. (2014) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 3
Fried, E. I. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14966 · Cited by 3
“Numerous large studies have documented surprisingly low antidepressant efficacy (e.g., Kirsch et al., 2008; Pigott et al., 2010), and clinicians are aware of the fact that some antidepressants have sedative effects, while others lead to improvement of motivation and energy5.”
BackgroundMENTAL HEALTH: YOUNG PEOPLE'S KNOWLEDGE, BELIEFS, ATTITUDES AND WISHES
Webster, A. M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
Walach, H. (2012) · Deutsche Zeitschrift für Akupunktur · doi:10.1016/j.dza.2012.02.006 · Cited by 1
“Der Verdacht wurde geäußert, dass es sich hier um Betrug in großem Stile zum Nachteil der Patienten und der Öff entlichkeit handelt [7], auch das Ende des biologisch-psychiatrischen Modells wurde beschworen [8].”
BackgroundPrescription for Critical Thinking: A Discussion of Psychotropic Medication and Counseling
Biggs, B. W. (2015) · JMU Scholoraly Commons (James Madison University) · Cited by 2
Agarwal, A. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/tbfj9 · Cited by 2
The Affective Disorder Test: a new test to assess depression and anxiety-like behaviour in rats
Blackburne, K. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16840765.v1 · Cited by 2
van Eijndhoven, P., Tendolkar, I., Loef, D., Rovers, J. J. E., Somers, M., Spaans, H., van Waarde, J. A., Schut, B., Wijnen, B. F. M., Verwijk, E., et al. (2024) · medRxiv · doi:10.1101/2024.03.21.24304665 · Cited by 6
Дмитриевна, Т. О., Агибалова, Т. В., Shustov, D. I., Shustova, S. A., Buzik, O. Z., & Petrosyan, Y. E. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611611261-68 · Cited by 2
Resveratrol as an add on therapy to sertraline in animal models of depression
Mohan, P., Avinash, K., Arun, J., Mishra, P., & Sinha, S. (2023) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2023.10.005 · Cited by 1
Christoforou, L., & Sutcliffe, K. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13445-7 · Cited by 2
Arboleda, S. R. (2022) · Cultura y Droga · doi:10.17151/culdr.2022.27.34.2 · Cited by 1
Neuropsychological Effects of Antidepressants: Translational Studies
Kamenish, K., & Robinson, E. S. J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_446 · Cited by 1
Pagliaccio, D. (2015) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7t151t3 · Cited by 2
Changing my mind: one professor’s story of rethinking psychotropic medication
Gum, A. M. (2015) · Journal of Medicine and the Person · doi:10.1007/s12682-015-0213-x · Cited by 1
Misselbrook, D. (2021) · British Journal of General Practice · doi:10.3399/bjgp21x716297 · Cited by 1
O’Shields, J., & Mowbray, O. P. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100316 · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
van Valkenhoef, G. H. M. (2012) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Temporal and population dynamics of depressive symptoms : empirical and modeling approaches
Rosenström, T. H. (2013) · Helda - University of Helsinki Institutional Repository · Cited by 1
Hammen, C. L., & Keenan‐Miller, D. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop208005 · Cited by 1
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1
Establishment of an Animal Model of Depression: The Serotonin Transporter Knockout Rat
Kidwell, M. (2019) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17135999 · Cited by 6
Antidepressant Research Controversies
Spielmans, G. I., & Kirsch, I. (2015) · Wiley eBooks · doi:10.1002/9781118625392.wbecp483
The discovery and development of drugs to treat psychiatric disorders: Historical perspective
Williams, M., & Barrett, J. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.002
DeBattista, C., & Hoffman, D. A. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.09.011
Metadata
- Authors
- Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J.
- Affiliations
- American University (US)
- ORCID
- Pigott, H. Edmund
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 79
- Issue
- 5
- Pages
- 267-279
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2020265264
- Cited by
- 347
- References
- 58
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 15 · 2023: 21 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 22 · 2018: 22 · 2017: 16 · 2016: 19 · 2015: 42 · 2014: 22 · 2013: 20 · 2012: 26
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, depression, antidepressant efficacy, publication bias, STAR*D trial, meta-analysis, selective outcome reporting, dropout rates
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, Publication Bias, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.